Psoriatic Arthritis News

Among women with peripheral psoriatic arthritis during and after pregnancy, disease activity was highest at 6 months following delivery, but in general was low and stable from pre-pregnancy to 1 year postpartum, according to data published in Arthritis Care & Research.

Although the Disease Activity Index for Psoriatic Arthritis based on 66 swollen or 68 tender joint counts remains the preferred measure, a modified version using just 28 joint counts demonstrated good criterion, correlational and construct validity and sensitivity to change for patients with low disease activity, according to recent data in the Annals of the Rheumatic Diseases.

When it comes to biologic therapy options, patients with rheumatoid arthritis are generally open to, and express high satisfaction with, IV treatments, according to findings published in Arthritis Care & Research.

Bone erosions are more dependent on a patient’s age and are enhanced in psoriatic arthritis, whereas enthesiophytes are more dependent on disease duration and are severe in both psoriasis and psoriatic arthritis, according to findings published in Arthritis Research & Therapy.

An international group of researchers proposed a more “refined” definition of autoinflammatory diseases and also proposed changes to the naming convention for these diseases, according to a report in Annals of the Rheumatic Diseases.

A study published in the International Journal of Geriatric Psychiatry reported that arthritis was highly prevalent among older adults with varying degrees of depression.

Incidence rates and prevalence of psoriatic arthritis and psoriasis in Ontario, Canada, have gradually increased throughout the past decade, and are now similar to those observed in Europe and the United States, according to findings published in Arthritis Care & Research.

Individuals with chronic inflammatory diseases continuously fight several adversaries, including pain, loss of functionality and complications due to treatment. Women of childbearing age who wish to start families can add two more opponents to that list: fear and misinformation.

The 2018 Rheumatic Disease Report Card: Raising the Grade on Rheumatology Care in America released today by the American College of Rheumatology demonstrates that access to affordable rheumatology care varied considerably from state to state, with most states averaging a “C” grade.

Under Medicare Part D drug benefits, the biosimilar infliximab-dyyb was only 18% less expensive than the infliximab reference product, exceeding $14,000 annually, according to a research letter published in JAMA.